ARTICLE | Company News
Takeda endocrine/metabolic news
June 1, 2015 7:00 AM UTC
Takeda agreed to pay $2.4 billion to settle all pending lawsuits filed by individuals who claimed to have been diagnosed with bladder cancer after taking diabetes drug Actos pioglitazone. Takeda did ...